Announcements Trials
Browse Landscape

Phase

Phase 2/3 2Phase EARLY_PHASE1 1Phase 2 1

Status

Recruiting 4Not yet recruiting 1Active not recruiting 1

Sponsor Class

INDUSTRY 4

Study Type

Interventional 4

Sponsor

Cancer Type

Gastrointestinal 2

Conditions

Breast Neoplasms 220Neoplasms 192Carcinoma, Non-Small-Cell Lung 185Colorectal Neoplasms 129Prostatic Neoplasms 119Lung Neoplasms 107Neoplasm Metastasis 91Multiple Myeloma 89Ovarian Neoplasms 85Pancreatic Neoplasms 78Squamous Cell Carcinoma of Head and Neck 71Leukemia, Myeloid, Acute 70Melanoma 61Stomach Neoplasms 56Recurrence 51Endometrial Neoplasms 50Brain Neoplasms 46Lymphoma 45Carcinoma, Renal Cell 45Carcinoma, Hepatocellular 45Glioblastoma 44Urinary Bladder Neoplasms 43Triple Negative Breast Neoplasms 43Precursor Cell Lymphoblastic Leukemia-Lymphoma 42Hematologic Neoplasms 40Esophageal Neoplasms 39Lymphoma, Large B-Cell, Diffuse 37Leukemia, Lymphocytic, Chronic, B-Cell 37Head and Neck Neoplasms 37Lymphoma, Non-Hodgkin 36

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

4 trials
RecentStart dateEnrollment
Recruiting × Cachexia × 30 days × Clear all
NCT06989437 2026-05-20

A Study to Learn About the Medicine Ponsegromab in Adults With Cancer of the Pancreas Which Has Spread and Caused Significant Body Weight Loss and Fatigue

Pfizer

Phase 2/3 Recruiting
982 enrolled
Gastrointestinal

Anorexia, Cachexia, Fatigue, Neoplasm Metastasis, Neoplasms, Pancreatic Neoplasms, Weight Loss

NCT07112196 2026-05-20

VINCIT

CatalYm GmbH

Phase 2/3 Recruiting
518 enrolled

Anorexia, Cachexia, Neoplasms, Weight Loss

NCT06736275 2026-05-15

A Phase I Study on Evaluating the Safety, Tolerability, Pharmacokinetic Characteristics and Preliminary Efficacy of SXRN Plasmid DNA Technique in Patients With Advanced Solid Tumors

Jiangsu Nutai Biologics Co., Ltd

Phase EARLY_PHASE1 Recruiting
28 enrolled

Cachexia

NCT06937177 2026-05-11

Safely Optimizing Body Weight With TCMCB07 in Patients With Newly Diagnosed Colorectal Cancer Undergoing Chemotherapy

Endevica Bio

Phase 2 Recruiting
120 enrolled
Gastrointestinal

Cachexia, Colorectal Neoplasms, Weight Loss

Data powered by HemOnc (CC BY 4.0) Colophon âš¡